RP5063, a dopamine serotonin stabilizer, was associated with symptom improvement in adults with acute exacerbation of schizophrenia or schizoaffective disorder.
Researchers sought to determine if functional magnetic resonance imaging could be used to predict treatment response in patients with major depressive disorder.
A recent study sought to determine if computer-based cognitive training had an impact on memory, concentration, and cognitive function in patients with tinnitus.